뉴스벤징가
New Partnership Gives Cartesian Therapeutics Another Shot At Autoimmune Disease Market
· 발표
기사 요약
Cartesian Therapeutics gains after licensing an in vivo CAR-T platform from WestGene, with a myasthenia gravis trial planned for 2026.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…